Reuters -- Sanofi-Aventis said on Wednesday independent experts had concluded that studies highlighting a possible link between its Lantus diabetes drug and an increased risk of cancer were flawed.
Reuters -- Sanofi-Aventis said on Wednesday independent experts had concluded that studies highlighting a possible link between its Lantus diabetes drug and an increased risk of cancer were flawed.
